Skip to main content
All lobbying filings

SAM ACTION, INC.

Lobbying for SAM ACTION, INC.

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Expenses
$70,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 6

Opposing the SAFE Banking Act.

Advocating for a prohibition on hemp-derived intoxicants and advocating for restrictions on prediction markets.

Advocating against CCP-operating marijuana farms.

Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), preventing the advocation of illegal drug use in anti-impaired driving advertisements, encouraging federal action against false therapeutic claims made about marijuana, and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.

Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)

Advocating for a federal ban on kratom.

 Bills named in this filing 2
  • S. 471
    No Deductions for Marijuana Businesses Act
  • H.R. 1447
    No Deductions for Marijuana Businesses Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem